Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA)

ClinicalTrials.gov ID: NCT00441727

Public ClinicalTrials.gov record NCT00441727. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 1:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Parallel-group, Multicentre, Phase III Study to Assess the Effect of Esomeprazole 20 or 40 mg od Versus Placebo on the Occurrence of Peptic Ulcers During 26 Weeks in Subjects on Continuous Low Dose Acetylsalicylic Acid (ASA)

Study identification

NCT ID
NCT00441727
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
2,426 participants

Conditions and interventions

Interventions

  • Esomeprazole 40 mg Drug
  • Esomeprazole 20 mg Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2007
Primary completion
Jul 31, 2008
Completion
Jul 31, 2008
Last update posted
Jul 15, 2012

2007 – 2008

United States locations

U.S. sites
55
U.S. states
26
U.S. cities
55
Facility City State ZIP Site status
Research Site Birmingham Alabama
Research Site Tucson Arizona
Research Site Anaheim California
Research Site Lancaster California
Research Site Los Angeles California
Research Site Orange California
Research Site San Carlos California
Research Site San Diego California
Research Site Torrington Connecticut
Research Site Boynton Beach Florida
Research Site Hollywood Florida
Research Site Jacksonville Florida
Research Site Jupiter Florida
Research Site Miami Florida
Research Site New Smyrna Beach Florida
Research Site Pembroke Pines Florida
Research Site Plantation Florida
Research Site South Miami Florida
Research Site Tampa Florida
Research Site Zephyrhills Florida
Research Site Fulton Illinois
Research Site Wichita Kansas
Research Site Shreveport Louisiana
Research Site Baltimore Maryland
Research Site Hollywood Maryland
Research Site Prince Frederick Maryland
Research Site Brockton Massachusetts
Research Site Jackson Mississippi
Research Site Las Vegas Nevada
Research Site Egg Harbor New Jersey
Research Site Albuquerque New Mexico
Research Site Great Neck New York
Research Site Fayetteville North Carolina
Research Site Greensboro North Carolina
Research Site Jacksonville North Carolina
Research Site Winston-Salem North Carolina
Research Site Centerville Ohio
Research Site Cincinnati Ohio
Research Site Dayton Ohio
Research Site Guthrie Oklahoma
Research Site Oklahoma City Oklahoma
Research Site Harrisburg Pennsylvania
Research Site Cranston Rhode Island
Research Site Johnston Rhode Island
Research Site Anderson South Carolina
Research Site Simpsonville South Carolina
Research Site Knoxville Tennessee
Research Site Houston Texas
Research Site Ogden Utah
Research Site Burke Virginia
Research Site Chesapeake Virginia
Research Site Christiansburg Virginia
Research Site Norfolk Virginia
Research Site Richmond Virginia
Research Site Milwaukee Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 134 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00441727, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 15, 2012 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00441727 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →